Androgen receptor pathway inhibitors, prostate cancer, and older adults: a global Young International Society of Geriatric Oncology drug review

Prostate cancer is a disease of older adults that has undergone a significant therapeutic paradigm shift in the last decade with the emergence of novel androgen receptor pathway inhibitors (ARPis). One of the more commonly used ARPis is enzalutamide. This drug, along with darolutamide and apalutamid...

Descripción completa

Detalles Bibliográficos
Autores principales: Mir, Nabiel, Burke, Olivia, Yates, Samuel, Rajasekaran, Tanujaa, Chan, Johan, Szmulewitz, Russell, Kanesvaran, Ravindran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9893362/
https://www.ncbi.nlm.nih.gov/pubmed/36743522
http://dx.doi.org/10.1177/17588359221149887

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9893362/
https://www.ncbi.nlm.nih.gov/pubmed/36743522
http://dx.doi.org/10.1177/17588359221149887

Ejemplares similares